Nicolò Antonio Miglio is an associate in the Milan office and his principal areas of practice are corporate law, Public and Private M&A and Equity Capital Markets. Nicolò regularly assists Italian and international companies and investment banks on a full range of commercial issues and transactions, on a multi-jurisdictional basis, across several sectors. His capital market experience includes advising on IPOs and right issues working with both issuers and underwriters involved in such transactions.
Italian pharma and consumer healthcare group Angelini in connection with its worldwide acquisition, outside North America, of ThermaCare from GlaxoSmithKline (GSK). The acquisition is a key transaction in relation to the creation of the GSK/Pfizer JV for Consumer Health.
Banca IMI, Bank of America Securities and UniCredit Corporate & Investment Banking, as Joint Global Coordinators and Joint Bookrunners, in connection with the initial public offering of Sanlorenzo S.p.A. on the STAR segment of the Milan Stock Exchange.
UniCredit Corporate & Investment Banking and Goldman Sachs International as Joint Global Coordinators and Joint Bookrunners in connection with the initial public offering of Piovan S.p.A. on the STAR segment of the Milan Stock Exchange. UniCredit Corporate & Investment Banking also acted as Sponsor.
Huvepharma in connection with its acquisition of the Animal Health Division of Neovia (InVivo Group).
Goldman Sachs and Blackstone Tactical Opportunities in connection with their investment in Prima Assicurazioni, an online insurance firm specialized in the distribution of automobile insurance policies.
Gamenet Group S.p.A. in connection with the issuance of its €225 million Senior Secured Guaranteed Floating Rate Notes due 2023.The notes have been offered and sold pursuant to Rule 144A and Regulation S under the Securities Act and listed on the Luxembourg Stock Exchange. The proceeds were used to finance the acquisition of GoldBet S.r.l.
An investment consortium led by CVC Capital Partners including PSP Investments and StepStone, in connection with the €3 billion acquisition from the Recordati family of the holding company that owns a 51.8 percent stake in the Italian pharmaceutical group Recordati.